Data from multiple sources - Curated by Marshall Pearce - Last updated 06 June 2017

Latest news articles

Added 13 days ago Drug news

FDA approves Zelboraf for Erdheim-Chester disease.- Genentech.

The FDA has approved Zelboraf (vemurafenib), from Genentech, for Erdheim-Chester disease (ECD) with BRAF V600 mutation.The approval is based on...

Added 2 months ago Drug news

The FDA has accepted for review a Biologics License Application (BLA) for a biosimilar candidate (TPI-G-CSF) referencing Neupogen (filgrastim).- Adello Biologics.

Adello Biologics announced that FDA has accepted for review the company’s Biologics License Application (BLA) for a biosimilar candidate (TPI-G-CSF)...

Added 2 months ago Drug news

Application to EU withdrawn for Fulphila (pegfilgrastim biosimilar) in neutropenia.- Mylan.

Mylan notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a...

Search all news articles for Diseases of white blood cells
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Psoriasis

Psoriasis

See information on psoriasis pathophysiology, signs and symptoms, comorbidities, treatment options, and more.

+ 2 more

IL-17A in Psoriasis

IL-17A in Psoriasis

Experts discuss new targeted therapies for psoriasis at the European Association of Dermatology and Venereology (EADV) Congress.

+ 1 more

Load more

Guidelines

Neutropenic sepsis: prevention and management in people with cancer

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Mortality rates ranging between 2% and 21% have...

Added 5 years ago

Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best...

Added 7 years ago

Management of febrile neutropenia: ESMO Clinical Practice Guidelines

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best...

Added 7 years ago

Search all guidelines for Diseases of white blood cells
 

Journal articles

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.

Ascertainment of cases and disease classification is an acknowledged problem for epidemiological research into haematological malignancies.

Added 2 months ago

Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial.

Background: Hypomethylating drugs are the standard treatment for patients with high-risk myelodysplastic syndromes. Survival is poor after failure of these...

Added 1 year ago

Search all journal articles for Diseases of white blood cells